Biopharma Culture

© Getty Images

Sania Therapeutics launches to advance novel medicines

By Isabel Cameron

Sania Therapeutics, a new biotech company focused on developing genetic medicines for neural circuit dysfunction, has launched by unveiling its suite of proprietary patented platforms at the American Society of Gene & Cell Therapy (ASGCT) conference.


DIA gears up for Global Annual Meeting

By Rachel Arthur

DIA, the professional global community for healthcare product development, will host its in-person Global Annual Meeting in Chicago on June 19-23.



US pharma hubs: The rising stars to watch

By Rachel Arthur

CPhI North America 2022 host city Philadelphia is set to become one of the world’s biggest cell and gene therapy manufacturing hubs. But it’s just one of many centers of innovation that are helping drive the US pharma and biopharma industry.


Syner-G Biopharma Group acquires Impact

By Rachel Arthur

Syner-G BioPharma Group, a provider of Chemistry, Manufacturing, and Controls (CMC) technical, regulatory, and compliance consulting services to the pharmaceutical and biotechnology industry, has acquired Impact Pharmaceutical Services.


DIA 2021 Annual Meeting

Skills of the future – and the future of work

By Rachel Arthur

Whether working in the pharmaceutical industry or in academia or government, the skills required to achieve, maintain and grow a career are vastly different today than they were 30 years ago. A session at DIA 2021 will put the spotlight on the skills...


Widening access to COVID-19 data

By Rachel Arthur

California information technology and services company Syntegra and the National Institutes of Health (NIH) have signed a partnership to 'democratize access to the largest set of COVID-19 patient records': with the use of Syntegra's synthetic...

Follow us